scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...878901Y |
P356 | DOI | 10.1371/JOURNAL.PONE.0078901 |
P932 | PMC publication ID | 3829817 |
P698 | PubMed publication ID | 24260134 |
P5875 | ResearchGate publication ID | 258825568 |
P2093 | author name string | Lei Fan | |
Chen Yang | |||
Zhi-Ming Shao | |||
Zhou-Luo Ou | |||
Ke-Da Yu | |||
Wen-Huan Xu | |||
Ao-Xiang Chen | |||
P2860 | cites work | A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. | Q52551923 |
Ionizing irradiation increases transcription of the von Willebrand factor gene in endothelial cells | Q71775695 | ||
The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity | Q77678719 | ||
Breast cancer progression and host polymorphisms in the chemokine system: role of the macrophage chemoattractant protein-1 (MCP-1) -2518 G allele | Q81341216 | ||
Chemokines and cancer | Q83278273 | ||
Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK | Q22253297 | ||
Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor | Q24305554 | ||
The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor | Q24679431 | ||
Cancer statistics, 2010 | Q27860525 | ||
Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6 | Q28257066 | ||
Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators | Q30495417 | ||
Development and trends of surgical modalities for breast cancer in China: a review of 16-year data | Q31115506 | ||
Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness | Q33602017 | ||
Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism | Q34307777 | ||
Contribution of Duffy antigen to chemokine function | Q34438414 | ||
Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential | Q34540077 | ||
Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines | Q36183730 | ||
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual | Q36383109 | ||
The inflammatory chemokines CCL2 and CCL5 in breast cancer | Q37148637 | ||
Regulators of chemokine receptor activity as promising anticancer therapeutics | Q37184781 | ||
Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. | Q39474536 | ||
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions. | Q39940205 | ||
Chemokine decoy receptor d6 plays a negative role in human breast cancer | Q39949918 | ||
The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors. | Q40481274 | ||
Multistep carcinogenesis of breast cancer and tumour heterogeneity | Q41540149 | ||
The removal of leukocytes and platelets from whole blood. | Q44677074 | ||
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients | Q46532483 | ||
Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression? | Q47300936 | ||
Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival | Q47967779 | ||
Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a – b–) phenotype | Q48071663 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metastatic potential | Q122615215 |
P304 | page(s) | e78901 | |
P577 | publication date | 2013-11-15 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer | |
P478 | volume | 8 |
Q38998705 | ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology |
Q40227745 | Atypical Chemokine Receptor 1 Polymorphism can not Affect Susceptibility to Hepatitis C Virus |
Q45324784 | Atypical Chemokine Receptor 1 polymorphism cannot be used as an indicator of liver fibrosis progression in Hepatitis C virus positive patients |
Q38747771 | Atypical chemokine receptors in cancer: friends or foes? |
Q57790433 | Effect of functional genetic variants in chemokine decoy receptors on the recurrence risk of breast cancer |
Q40202351 | Impact of genetic polymorphisms determining leukocyte/neutrophil count on chemotherapy toxicity |
Q64924555 | Meta-Analysis of Autoimmune Regulator-Regulated Genes in Human and Murine Models: A Novel Human Model Provides Insights on the Role of Autoimmune Regulator in Regulating STAT1 and STAT1-Regulated Genes. |
Q45762115 | ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K/Akt/NF-κB signaling pathway |
Q64118708 | The Interplay Between Lymphatic Vessels and Chemokines |
Q90649378 | The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses |
Q38254356 | The potential to target CCL5/CCR5 in breast cancer. |